Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 3
1976 4
1977 7
1978 5
1979 9
1980 2
1981 10
1982 7
1983 8
1984 7
1985 6
1986 6
1987 4
1988 7
1989 9
1990 6
1991 20
1992 7
1993 12
1994 5
1995 7
1996 9
1997 3
1998 10
1999 8
2000 3
2001 8
2002 10
2003 14
2004 7
2005 9
2006 15
2007 18
2008 12
2009 13
2010 14
2011 15
2012 11
2013 6
2014 14
2015 13
2016 10
2017 12
2018 17
2019 16
2020 17
2021 14
2022 19
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Results by year

Filters applied: . Clear all
Page 1
Randomized clinical trial with fractional CO(2) laser and Clobetasol in the treatment of Vulvar Lichen Sclerosus: a clinic study of feasibility.
Salgado HC, Drumond DG, Pannain GD, de Melo E Costa LG, Sampaio FS, Leite ICG. Salgado HC, et al. BMC Res Notes. 2023 Mar 10;16(1):33. doi: 10.1186/s13104-023-06300-7. BMC Res Notes. 2023. PMID: 36894959 Free PMC article. Clinical Trial.
OBJECTIVES: The main objective of the study was to describe and compare the feasibility of using fractional CO(2) laser to the usual treatment with Clobetasol. Randomized clinical trials brought together 20 women from a Brazilian university hospital, 9 of them were submitt …
OBJECTIVES: The main objective of the study was to describe and compare the feasibility of using fractional CO(2) laser to the usual treatme …
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.
Bekaii-Saab TS, Ou FS, Ahn DH, Boland PM, Ciombor KK, Heying EN, Dockter TJ, Jacobs NL, Pasche BC, Cleary JM, Meyers JP, Desnoyers RJ, McCune JS, Pedersen K, Barzi A, Chiorean EG, Sloan J, Lacouture ME, Lenz HJ, Grothey A. Bekaii-Saab TS, et al. Lancet Oncol. 2019 Aug;20(8):1070-1082. doi: 10.1016/S1470-2045(19)30272-4. Epub 2019 Jun 28. Lancet Oncol. 2019. PMID: 31262657 Free PMC article. Clinical Trial.
Clobetasol usage plans (0.05% clobetasol cream twice daily applied to palms and soles) were either pre-emptive or reactive. After randomisation to the four preplanned groups, using the Pocock and Simon dynamic allocation procedures stratified by the treating hospita
Clobetasol usage plans (0.05% clobetasol cream twice daily applied to palms and soles) were either pre-emptive or reactive. Af
Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
Lajevardi V, Ghiasi M, Balighi K, Daneshpazhooh M, Azar PM, Kianfar N, Dasdar S, Peymanfar AA. Lajevardi V, et al. Dermatol Ther. 2022 Nov;35(11):e15868. doi: 10.1111/dth.15868. Epub 2022 Oct 9. Dermatol Ther. 2022. PMID: 36169160 Clinical Trial.
The mean of LPPAI at baseline and last session were 4.68 1.97 and 2.59 0.97 in the clobetasol group and 5.01 1.71 and 3.04 1.36 in the pioglitazone group, respectively. ...It can be considered a treatment option for LPP, although it was not superior to clobetasol... …
The mean of LPPAI at baseline and last session were 4.68 1.97 and 2.59 0.97 in the clobetasol group and 5.01 1.71 and 3.04 1.36 in th …
Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease.
Noce CW, Gomes A, Shcaira V, Corrêa ME, Moreira MC, Silva Júnior A, Gonçalves LS, Garnica M, Maiolino A, Torres SR. Noce CW, et al. Biol Blood Marrow Transplant. 2014 Aug;20(8):1163-8. doi: 10.1016/j.bbmt.2014.04.009. Epub 2014 Apr 13. Biol Blood Marrow Transplant. 2014. PMID: 24727333 Free article. Clinical Trial.
Thirty-five patients were recruited, and 32 patients were randomized into the study groups: 18 patients (56.3%) to the dexamethasone group and 14 patients (43.8%) to the clobetasol group. The use of clobetasol resulted in a significant reduction in mOMRS total score …
Thirty-five patients were recruited, and 32 patients were randomized into the study groups: 18 patients (56.3%) to the dexamethasone group a …
Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: A phase 2 randomized clinical trial.
Brennan MT, Madsen LS, Saunders DP, Napenas JJ, McCreary C, Ni Riordain R, Pedersen AML, Fedele S, Cook RJ, Abdelsayed R, Llopiz MT, Sankar V, Ryan K, Culton DA, Akhlef Y, Castillo F, Fernandez I, Jurge S, Kerr AR, McDuffie C, McGaw T, Mighell A, Sollecito TP, Schlieve T, Carrozzo M, Papas A, Bengtsson T, Al-Hashimi I, Burke L, Burkhart NW, Culshaw S, Desai B, Hansen J, Jensen P, Menné T, Patel PB, Thornhill M, Treister N, Ruzicka T. Brennan MT, et al. J Oral Pathol Med. 2022 Jan;51(1):86-97. doi: 10.1111/jop.13270. Epub 2022 Jan 13. J Oral Pathol Med. 2022. PMID: 34907617 Clinical Trial.
We report on the efficacy and safety of a novel mucoadhesive clobetasol patch (Rivelin() -CLO) for the treatment of OLP. METHODS: Patients with confirmed OLP and measurable symptomatic ulcer(s) participated in a randomized, double-blind, placebo-controlled, multicenter cli …
We report on the efficacy and safety of a novel mucoadhesive clobetasol patch (Rivelin() -CLO) for the treatment of OLP. METHODS: Pat …
Non-invasive clinical and microscopic evaluation of the response to treatment with clobetasol cream vs. calcipotriol/betamethasone dipropionate foam in mild to moderate plaque psoriasis: an investigator-initiated, phase IV, unicentric, open, randomized clinical trial.
Yélamos O, Alejo B, Ertekin SS, Villa-Crespo L, Zamora-Barquero S, Martinez N, Domínguez M, Iglesias P, Herrero A, Malvehy J, Puig S. Yélamos O, et al. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):143-149. doi: 10.1111/jdv.16559. Epub 2020 Jul 6. J Eur Acad Dermatol Venereol. 2021. PMID: 32365242 Free PMC article. Clinical Trial.

At week 4, more patients treated with Cal/BD foam achieved TCS 1 than with clobetasol (63.2% vs. 18.8%, P = 0.016). Treatment satisfaction was higher with Cal/BD foam (P < 0.03). ...If epidermal hyperplasia was noted at baseline, the response was poorer with clobetas

At week 4, more patients treated with Cal/BD foam achieved TCS 1 than with clobetasol (63.2% vs. 18.8%, P = 0.016). Treatment satisfa …
Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
Xia L, Li R, Wang Y, Lin Z, Zheng J, Li X, Lu Q, Zhang J, Jin H, Fu L, Zhang X, Liu Y, Yang S, Xiao F, Gao XH. Xia L, et al. Dermatol Ther. 2018 Sep;31(5):e12632. doi: 10.1111/dth.12632. Epub 2018 Sep 25. Dermatol Ther. 2018. PMID: 30253049 Clinical Trial.
To assess the efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment and calcipotriol/betamethasone dipropionate ointment in the treatment of mild-to-moderate patients with psoriasis vulgaris. ...A total of 240 patients …
To assess the efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment and calcipo …
Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: A double-blinded, randomized clinical trial in Sri Lanka.
Hettiarachchi PVKS, Hettiarachchi RM, Jayasinghe RD, Sitheeque M. Hettiarachchi PVKS, et al. J Investig Clin Dent. 2017 Nov;8(4). doi: 10.1111/jicd.12237. Epub 2016 Sep 15. J Investig Clin Dent. 2017. PMID: 27633647 Clinical Trial.
Patients were randomly divided into two groups of 34 patients each to receive topical tacrolimus 0.1% cream or clobetasol propionate 0.05% cream for 3 weeks. RESULTS: After 3 weeks of treatment, the mean pain score dropped by 1.59 (right) and 1.53 (left) in the tacrolimus …
Patients were randomly divided into two groups of 34 patients each to receive topical tacrolimus 0.1% cream or clobetasol propionate …
The comparison of therapeutic effect of Clobetasol propionate lotion and squill extract in alopecia areata: a randomized, double-blind clinical trial.
Moosavi ZB, Aliabdi M, Golfakhrabadi F, Namjoyan F. Moosavi ZB, et al. Arch Dermatol Res. 2020 Apr;312(3):173-178. doi: 10.1007/s00403-019-02004-w. Epub 2019 Nov 9. Arch Dermatol Res. 2020. PMID: 31707498 Clinical Trial.
From the past, Urginea maritima (white squill) was used for the treatment of hair loss in Iranian traditional medicine. We aimed the comparison of Clobetasol lotion and squill extract efficacy in treatment of alopecia areata in a randomized, double-blind clinical trial. Th …
From the past, Urginea maritima (white squill) was used for the treatment of hair loss in Iranian traditional medicine. We aimed the compari …
Efficacy, safety, tolerability, and satisfaction of N-acetylcysteine and pentoxifylline in lichen planopilaris patients under treatment with topical clobetasol: A triple arm blinded randomized controlled trial.
Ahmadi Kahjoogh H, Yazdanian N, Behrangi E, Roohaninasab M, Hejazi P, Goodarzi A. Ahmadi Kahjoogh H, et al. Dermatol Ther. 2022 Aug;35(8):e15639. doi: 10.1111/dth.15639. Epub 2022 Jun 24. Dermatol Ther. 2022. PMID: 35703373 Clinical Trial.
In a randomized, assessor- and analyst-blinded controlled trial, patients with proven LPP were randomly assigned to three groups of 10. Group I (the control group) received clobetasol 0.05%lotion; Group II, a combination of clobetasol 0.05% lotion and oral PTX; Grou …
In a randomized, assessor- and analyst-blinded controlled trial, patients with proven LPP were randomly assigned to three groups of 10. Grou …
438 results